Science and Health News

Intranasal insulin spray warrants further testing for age-related decline, researchers say

A team led by the Institut de Neurociències at the Universitat Autònoma de Barcelona (INc-UAB) managed to reduce chronic inflammation associated with multiple sclerosis in mice thanks to the administration of a type of lipid that mediates inflammation. The team found that these types of mediator substances, responsible for resolving the inflammatory process when it is no longer beneficial, are minimized in people with multiple sclerosis as well as in animal models of the disease. The use of these mediators could become a good strategy for the treatment of this autoimmune disease.

Genetic variants in an enzyme that is important to mitochondrial function may contribute to whether individuals maintain or lose strength and mobility as they age.

The study, published in the prestigious journal Science Robotics, was led by Philippe Malcolm, Ph.D., assistant professor in biomechanics at UNO, marking a new milestone for high-impact institutional research.

A research group led by Sa Kan Yoo at the RIKEN Center for Biosystems Dynamics Research (BDR) has discovered a completely unknown type of cell death that takes place in the guts of the common fruit fly. The new process, coined “erebosis” by the researchers is thought to play a role in gut metabolism. The findings necessitate a revision of the conventional concept of cell death, and at the same time, overturn the previously established theory of tissue homeostasis in the gut. The study was published April 25 in scientific journal PLOS Biology.

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, shared topline data from an ongoing Phase 1/2/3 trial evaluating ARCT-154, Arcturus’ self-amplifying mRNA vaccine candidate against COVID-19 disease caused by the SARS-CoV-2 virus.

A new study has linked life satisfaction to the chemistry in our brains.

Researchers at the University of East Anglia have found a link between bacteria and aggressive forms of prostate cancer.